Becton Dickinson and Company (BDX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $59.39B
Last updated: Nov 17, 2026 at 11:05 AM ET
Becton Dickinson and Company (BDX) P/E Ratio & Valuation History
Becton Dickinson and Company (BDX) trades at 16.4x trailing earnings and 2.6x sales. Its P/E of 16.4x is below its 5-year median of 18.9x. Its forward P/E is 16.4x. The median P/E across 12 similar companies is 20.9x.
Current Multiples
Its enterprise value is 15.6x its EBITDA. Its free cash flow yield is 5.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 16.4x |
| Forward P/E | 16.4x |
| Price to sales | 2.6x |
| Price to book | 2.4x |
| EV/EBITDA | 15.6x |
| Price to FCF | 18.4x |
| EV/FCF | 23.4x |
| PEG | 1.0 |
| FCF yield | 5.4% |
Historical Medians
Against its 10-year medians, its P/E is 20.0% below 20.5x, its P/S is 31.6% below 3.8x and its P/B is 17.2% below 2.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 16.4x | 18.9x | 20.5x |
| P/S | 2.6x | 3.5x | 3.8x |
| P/B | 2.4x | 2.7x | 2.9x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 14.0x in 2025 to 23.4x in 2019. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $194.07 | 14.0x | 2.5x | 2.2x |
| 2024 | $226.87 | 16.3x | 3.2x | 2.6x |
| 2023 | $243.83 | 20.5x | 3.6x | 2.8x |
| 2022 | $254.30 | 22.0x | 3.9x | 2.8x |
| 2021 | $251.48 | 20.7x | 3.9x | 3.0x |
| 2020 | $250.22 | 20.7x | 4.2x | 2.9x |
| 2019 | $271.97 | 23.4x | 4.3x | 3.5x |
| 2018 | $225.32 | 20.1x | 3.5x | 2.8x |
| 2017 | $214.06 | 22.2x | 4.1x | 2.7x |
| 2016 | $165.55 | 18.4x | 2.9x | 4.6x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BDX
What is BDX's forward P/E ratio?
Becton Dickinson and Company has a forward P/E ratio of 16.4x.
Is BDX stock overvalued?
GNG's valuation label for BDX is Fairly valued. Its P/E of 16.4x compares with a median of 20.9x across 12 similar companies.
What is BDX's price to sales ratio?
Becton Dickinson and Company has a price to sales ratio of 2.6x.
What is Becton Dickinson and Company's average P/E ratio over 5 years?
Becton Dickinson and Company's median P/E over the last 5 years is 18.9x, from 60 month-end values through Oct 2026.
What is BDX's PEG ratio?
Becton Dickinson and Company has a PEG ratio of 1.0.
BDX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors